LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
07/28/2026
Back to search
Official data from USPTO
SPLEEN TO SCREEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
SPLEEN TO SCREEN
ST13
US500000079227419Class
1, 5, 42, 44, 45
Filing
79227419
Registration
5830546
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
64
Latest update
07/28/2026
Classification
Registered
Trademark type
Word
Nice classes
1, 5, 42, 44, 45
Filing date
07/21/2017
Registration date
08/13/2019
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/11/2026
Last transaction
07/28/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
NL
Examiner
NELMAN, JESSE M
Current location
Historical data usage
Holders and representatives
Holders
Merus B.V.
Merus N.V.
Representatives
Max Vern Amster, Rothstein & Ebenstein LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biochemical products used in the medical and pharmaceutical industry and in sciencein particular antibodies in the nature of protein mixtures for rapidly screening panels of target-specific antibodies for the downstream production offor the manufacture ofmono and multispecific biologics being biological preparations in the fields of immuno-oncology and auto-immune diseases
Class 5
Pharmaceutical and veterinary preparations prepared with antibodies in the nature of protein mixtures used in the medical and pharmaceutical industry and in science for the treatment of cancer and other therapeutic indicationsfor the generation of mono and multispecific biologics being biological preparations in the fields of immuno-oncology and auto-immune diseases
Class 42
Services of biochemistsscientific and medical laboratory services in the nature of efficient screening of antibodies in the nature of protein mixtures for the generation of mono and multispecific biologics; services of bacteriologic and biochemical laboratoriesresearch in the field of biochemistry; professional advice relating to biochemistry; conducting scientific and industrial research using laboratory techniquesthe extractionfragmentationcloningtransformationisolationconcatenationcomplementingselectionidentification and compilation of cells and genetic materials in the nature of DNA and preparing related professional reports; professional advice relating to scientific and industrial research using laboratory techniquesthe extractionfragmentationcloningtransformationisolationconcatenationcomplementingselectionidentification and compilation of cells and genetic materials in the nature of DNA and the preparation of related professional reports; reviewing and analyzing anti-bodies in the nature of protein mixtures used in the medical and pharmaceutical industry and in science and the preparation of related professional reports for scientistsengineersanalysts and laboratory assistants and technicians for industry and government services; scientific and industrial researchin particular in the field of the aforementioned anti-bodiesanti-bodies in the nature of protein mixtures; research and development of new products for othersin particular anti-bodies in the nature of protein mixtures; chemical and laboratory research servicesperforming extractionfragmentationcloningtransformationisolationconcatenationcomplementingselectionidentification and compilation of cells and genetic materials in the nature of DNA and the preparation of related professional reports; consultancy relating to chemical and laboratory research servicesthe performance of extractionfragmentationcloningtransformationisolationconcatenationcomplementingselectionidentification and compilation of cells and genetic materials in the nature of DNA and the preparation of related professional reports
Class 44
Medical services; veterinary services; genetic testing of research animalsin particular of transgenic mice for research purposes
Class 45
Legal services; legal services relating to exploitation of intellectual property rights; licensing of intellectual property rights; legal advisory services in the aforementioned fieldsexploitation of intellection property rights and licensing of intellectual property rightsconcerning rapid screening of panels of target-specific antibodies for the downstream production offor the manufacture ofmono and multispecific biologics in the fields of immuno-oncology and auto-immune diseases
Publications
History of USPTO decisions and trademark events.
64 publications found
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
06/11/2026
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
06/11/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/01/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/28/2026
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/28/2026
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
05/28/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/28/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/28/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/28/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/28/2026
RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
05/07/2026
CHLD
CHANGE OF OWNER RECEIVED FROM IB
03/19/2026
ES75
TEAS SECTION 71 & 15 RECEIVED
02/13/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/09/2026
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/09/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/09/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/09/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/13/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/30/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/30/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/30/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/30/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/30/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/30/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/30/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/13/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/26/2019
FIMP
FINAL DISPOSITION PROCESSED
11/26/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/13/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
08/13/2019
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/09/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/24/2019
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/24/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/28/2019
PUBO
PUBLISHED FOR OPPOSITION
05/28/2019
GPNX
NOTIFICATION PROCESSED BY IB
05/24/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/08/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/08/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/08/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/19/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
04/19/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/19/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
04/19/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/19/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/03/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/03/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/03/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/09/2018
GNRT
NON-FINAL ACTION E-MAILED
10/09/2018
CNRT
NON-FINAL ACTION WRITTEN
10/09/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/14/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/14/2018
ALIE
ASSIGNED TO LIE
09/14/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/05/2018
RFNT
REFUSAL PROCESSED BY IB
03/24/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/08/2018
RFRR
REFUSAL PROCESSED BY MPU
03/08/2018
MAFR
APPLICATION FILING RECEIPT MAILED
03/06/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/02/2018
CNRT
NON-FINAL ACTION WRITTEN
03/01/2018
DOCK
ASSIGNED TO EXAMINER
02/28/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/28/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/22/2018
Continuous trademark protection
Get notified about every new filing that threatens SPLEEN TO SCREEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.